DHA-Derived Lipid Compounds Show Promise for Gum Inflammation in Lab and Animal Study
This laboratory and animal study looked at a blend of lipid mediators naturally produced from docosahexaenoic acid (DHA), an omega-3 fatty acid, using a soybean enzyme. The blend contained three specific compounds: 17S-HDHA, resolvin D5, and protectin DX.
In human gum cells exposed to bacterial toxins, the lipid mediator blend reduced markers of inflammation, including nitric oxide, prostaglandin E2, several inflammatory cytokines, and an enzyme (MMP9) linked to tissue breakdown. These effects were tied to reduced activity in two inflammation-related signaling pathways, NF-κB and STAT3.
In a rat model of periodontitis created using a ligature technique, daily oral doses of the lipid mediator blend reduced gum inflammation and helped limit bone loss around the teeth, as measured by imaging and tissue analysis.
What this means for you
This early-stage research, done in cells and animals rather than people, suggests that specialized lipid compounds derived from DHA may help calm inflammatory pathways involved in gum disease. It’s a promising signal for future human research, not evidence that any supplement can treat or prevent periodontitis.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.